If the market takes off and SKUL does not perform in Sep. then one would consider taking that $$$$ and putting it in the beaten down names in the Industrial, Mining and Coal sector. 90% of hedgies are under-performing the market and they will run these names up (CAT, VALE, BTU, CLF, FCX... Just to name a few)
I still believe in SKUL. The fundimentals are solid. It may take some time. I'm still long.
Like most of us, I'm still in the money with a lot of reasons to hold this stock.
Go long - be strong - go SKULnation
I use to sell equipment to Pharma / Biotech companies. They spend money like water.
I'm not familiar with SPPI as I never called on them. Interesting business model but I would assume they pay BIG bucks for approved drugs and it takes awhile to get the payback once they are on the market (depending on the drug).
I called on a bunch of start-up biotech companies that would be around for a couple of years trying to get Phase III approval on drugs and they would fold and the same guys would start up another company in a year or 2.
Just babbling here...
From what I understand, SPPI buys and markets drugs already approved. They were also just given permission by the Federal Trade Commission to purchase Allos Pharma. They're just about as profitable as QCOR which only markets one drug and also has a huge short interest. I'm attracted to PROFITABLE companies with little debt, alot of cash and large SI. I need a better understanding of the technical side of trading/investing.